Cargando…

Searching for Second Hits for the Development of APOL1-Associated Kidney Disease

Detalles Bibliográficos
Autores principales:	Husain, S. Ali, Chang, Jae-Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611946/ https://www.ncbi.nlm.nih.gov/pubmed/31317111 http://dx.doi.org/10.1016/j.ekir.2019.05.007

Ejemplares similares

New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease
por: Ross, Michael J.
Publicado: (2019)

Transcription and translation of APOL1 variants
por: Ejaz, Samina
Publicado: (2017)

APOL1-Associated Kidney Disease in Brazil
por: Riella, Cristian, et al.
Publicado: (2019)

Launching APOLLO: The Role of APOL1 Genetic Variants in Live- and Deceased-Donor Kidney Transplantation
por: Fuentes, Federico, et al.
Publicado: (2019)

A Focus on APOL1 and Kidney Disease
por: Nestor, Jordan, et al.
Publicado: (2019)

APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene − Proceedings of the Henry Shavelle Professorship
por: Pollak, Martin R., et al.
Publicado: (2023)

Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys
por: Blessing, Natalya A., et al.
Publicado: (2021)

Late Reoccurrence of Collapsing FSGS After Transplantation of a Living-Related Kidney Bearing APOL 1 Risk Variants Without Disease Evident in Donor Supports the Second Hit Hypothesis
por: Kalil, Roberto S., et al.
Publicado: (2017)

APOL1, Sickle Cell Trait, and Glutathione S-Transferase 1—More Complicated Than It Seems
por: Kruzel-Davila, Etty, et al.
Publicado: (2022)

Effect of APOL1 disease risk variants on APOL1 gene product
por: Haque, Shabirul, et al.
Publicado: (2017)

APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin
por: Uzureau, Sophie, et al.
Publicado: (2020)

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
por: McCarthy, Gizelle M., et al.
Publicado: (2021)

APOL1 Toxin, Innate Immunity and Kidney Injury
por: Limou, Sophie, et al.
Publicado: (2015)

Should kidney donors be genotyped for APOL1 risk alleles?
por: Freedman, Barry I., et al.
Publicado: (2015)

APOL1 Kidney-Risk Variants Induce Mitochondrial Fission
por: Ma, Lijun, et al.
Publicado: (2020)

Commentary: Getting HIT with HIT minus T (thrombosis without thrombocytopenia)
por: Edwin, Frank, et al.
Publicado: (2020)

Sequencing rare and common APOL1 coding variants to determine kidney disease risk
por: Limou, Sophie, et al.
Publicado: (2015)

APOL1 risk variants and kidney disease: what we know so far
por: Siemens, Tobias August, et al.
Publicado: (2018)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians
por: Tayo, Bamidele O., et al.
Publicado: (2012)

Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association
por: Bentley, Amy Rebecca, et al.
Publicado: (2012)

SMOC2 gene interacts with APOL1 in the development of end-stage kidney disease: A genome-wide association study
por: Chaudhary, Ninad S., et al.
Publicado: (2022)

Erratum to: Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians
por: Tayo, Bamidele O., et al.
Publicado: (2014)

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans
por: Matsha, Tandi E, et al.
Publicado: (2015)

APOL1 genotyping via buccal mucosa cell samples to establish risk of kidney disease
por: Alladagbin, Dona Jeanne, et al.
Publicado: (2022)

Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations
por: Giudicelli, Giovanna Câmara, et al.
Publicado: (2022)

Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options
por: Vasquez-Rios, George, et al.
Publicado: (2023)

The metabolic effects of APOL1 in humans
por: Adeva-Andany, María M., et al.
Publicado: (2023)

APOL1 Risk Genotypes Are Associated With Early Kidney Damage in Children in Sub-Saharan Africa
por: Ekulu, Pepe M., et al.
Publicado: (2019)

Hitting HIV where it hides
por: Dayton, Andrew I
Publicado: (2008)

APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans
por: Bentley, Amy R., et al.
Publicado: (2015)

No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations
por: Kimuda, Magambo Phillip, et al.
Publicado: (2018)

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
por: Hughson, Michael D., et al.
Publicado: (2017)

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury
por: Andrews, Michael, et al.
Publicado: (2022)

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale
por: Freedman, Barry I., et al.
Publicado: (2019)

Association of preeclampsia with infant APOL1 genotype in African Americans
por: Miller, Anna K., et al.
Publicado: (2020)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Copy Number Variation at the APOL1 Locus
por: Ruchi, Rupam, et al.
Publicado: (2015)

Lessons From APOL1 Animal Models
por: Yoshida, Teruhiko, et al.
Publicado: (2021)

Association Between APOL1 Genotype and Kidney Diseases and Annual Kidney Function Change: A Systematic Review and Meta-Analysis of the Prospective Studies
por: Jagannathan, Ram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1cmgu2sn9qtapmio5er1gasiu